States continue regulatory onslaught against PBMs
(By Jakob Emerson for Becker’s Hospital Review) State legislative efforts to regulate or increase transparency policies around pharmacy benefit managers
Read More
Legislative Update
Here’s who Democrats’ drug pricing bill will actually help
(By Rachel Cohrs for STAT) WASHINGTON — Millions of patients in the Medicare program could eventually see lower prescription drug
Read MoreCongress is about to act on drug price reform. Here’s what you need to know
(By Selena Simmons-Duffin and Allison Aubrey for NPR) Americans pay way more than people in other countries do for prescription
Read MoreMedicare Advantage prior authorization bill advances
(By Andrew Cass for Becker’s Hospital Review) The U.S. House Ways & Means Committee advanced a bill to reform the
Read MoreHouse passes bill extending Medicare telehealth flexibilities
(By Noah Schwartz for Becker’s Hospital Review) The United States House of Representatives passed a bill expanding telehealth services and
Read MoreNew law will require drug manufacturers to provide refunds to CMS for certain discarded drugs.
The Centers for Medicare and Medicaid Services data from 2020 shows the agency paid almost $720 million for discarded drugs
Read MoreSenate Democrats advance plan to give Medicare drug price negotiation powers: 6 notes
(By Jakob Emerson for Becker’s Hospital Review) U.S. Senate Democrats reached a legislative agreement June 6 that would allow Medicare
Read MoreSeeking to Kick-Start Biden’s Agenda, Schumer Unveils a Bill for Medicare Drug Price Negotiations
(By Michael McAuliff for Kaiser Health News) Democratic senators on Wednesday took a formal step toward reviving President Joe Biden’s
Read MoreHow Much Health Insurers Pay for Almost Everything Is About to Go Public
(By Julie Appleby for Kaiser Health News) Consumers, employers, and just about everyone else interested in health care prices will
Read MoreCMS rule limiting 3rd-party Medicare Advantage, Part D marketing now in effect
(By Jakob Emerson for Becker’s Hospital Review) A CMS rule revising Medicare Advantage and Part D marketing and communication regulations
Read More